Clinical Trials Directory

Trials / Completed

CompletedNCT03475160

Sildenafil Citrate and Recurrent Abortion

Sildenafil Citrate for Treatment of Unexplained Recurrent Spontaneous Abortion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Benha University · Academic / Other
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Two groups of unexplained recurrent spontaneous abortion, each included 65 participants. scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The intervention started from day 21-23 of the cycle preceding spontaneous pregnancy and continued till the 12th-week of gestation. The primary outcome measure was the difference in the live birth between both groups. Secondary outcome measures were the differences between both groups regard pulsatility index (PI) and resistance index (RI), a number of take-home babies, the reported side-effects of treatment and the pregnancy-related complications.

Detailed description

Two groups of unexplained recurrent spontaneous abortion, each included 65 participants. scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The intervention started from day 21-23 of the cycle preceding spontaneous pregnancy and continued till the 12th-week of gestation. The primary outcome measure was the difference in the live birth between both groups. Secondary outcome measures were the differences between both groups regard PI and RI, a number of take-home babies, the reported side-effects of treatment and the pregnancy-related complications, e.g., preeclampsia and intrauterine growth restriction (\|IUGR).

Conditions

Interventions

TypeNameDescription
DRUGSildenafil Citrate vaginal suppositoriesSildenafil citrate vaginal suppositories. Uterine artery Doppler before treatment. Uterine artery Doppler after treatment.
DRUGPlacebo vaginal suppositoriesPlacebo vaginal suppositories. Uterine artery Doppler before treatment. Uterine artery Doppler after treatment.
PROCEDUREUterine artery Doppler before treatmentUterine artery Doppler before treatment: Uterine artery Doppler indices; PI and RI at cycle days 21-23 of the cycle preceding the pregnancy
PROCEDUREUterine artery Doppler after treatmentUterine artery Doppler after treatment: Uterine artery Doppler indices; PI and RI at the twelfth week of gestation

Timeline

Start date
2015-12-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2018-03-23
Last updated
2018-03-23

Source: ClinicalTrials.gov record NCT03475160. Inclusion in this directory is not an endorsement.